Position in MYGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,637,199
-$610,361 QoQ
Shares Held
363,822
-0.4% QoQ
Ownership
0.385%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $46,471,273 across 10 Diagnostics & Research names. MYGN ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
37,115 | $17,822,251 | |
| 2 | SHC |
Sotera Health Co
|
427,890 | $6,135,942 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
9,945 | $5,587,996 | |
| 4 | GH |
Guardant Health, Inc.
|
57,430 | $5,304,809 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
362,710 | $5,034,414 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
14,720 | $2,539,200 | |
| 7 | MYGN |
Myriad Genetics Inc
This page
|
363,822 | $1,637,199 | |
| 8 | CSTL |
Castle Biosciences Inc
|
34,778 | $853,799 |
All Filings in MYGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,637,199 | 363,822 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,247,560 | 365,457 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,601,459 | 913,065 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,601,460 | 180,548 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $823,943 | 60,098 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $582,859 | 21,280 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $221,314 | 9,048 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||